Chronic Pain News and Research RSS Feed - Chronic Pain News and Research

Study explores thoughts among accredited physical therapy schools on pain education

A study published in The Journal of Pain showed that just 2 of 3 accredited physical therapy (PT) schools surveyed believe their students receive adequate education in pain management. [More]
New study shows how anterior cingulate cortex can be stimulated to control pain

New study shows how anterior cingulate cortex can be stimulated to control pain

A new study by a University of Texas at Arlington physics team in collaboration with bioengineering and psychology researchers shows for the first time how a small area of the brain can be optically stimulated to control pain. [More]
New, first-of-its-kind app helps patients with chronic pain track opioid use

New, first-of-its-kind app helps patients with chronic pain track opioid use

A new, first-of-its-kind app has launched to help patients suffering from chronic pain track their opioid use and measure pain levels to assist with the safe use of opioids. [More]
PCORI funds five patient-centered comparative effectiveness research studies

PCORI funds five patient-centered comparative effectiveness research studies

The Patient-Centered Outcomes Research Institute Board of Governors today approved awards totaling more than $64 million to fund five large patient-centered comparative effectiveness research (CER) studies that will answer critical clinical questions about care for cancer, back pain, and stroke. [More]
CHLA pediatric expert answers questions about PTSD

CHLA pediatric expert answers questions about PTSD

PTSD. Four letters we immediately associate with soldiers and horrific wartime tragedies. But unfortunately, posttraumatic stress disorder (PTSD) can affect anyone who has experienced a traumatic event—including children with serious medical diagnoses. [More]
Saluda Medical receives $10 million in Series B financing

Saluda Medical receives $10 million in Series B financing

Saluda Medical has today announced that it has received $10 million in Series B financing bringing a breakthrough treatment for chronic pain one step closer to reality. [More]
New planning tool helps identify patients' risks of chronic pain after surgery

New planning tool helps identify patients' risks of chronic pain after surgery

There are many variables that contribute to a patient's risk of chronic pain after surgery; physicians are still exploring ways to identify those variables prior to surgery. [More]
International study shows potential new therapy to treat patients with neuropathic pain

International study shows potential new therapy to treat patients with neuropathic pain

An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain. [More]
BUSM's medical education program wins HIDTA award for Outstanding Prevention Effort

BUSM's medical education program wins HIDTA award for Outstanding Prevention Effort

White House Drug Control Policy Director Michael Botticelli has awarded Boston University School of Medicine's Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program a 2014 National High Intensity Drug Trafficking Area (HIDTA) award for Outstanding Prevention Effort. [More]
New compound appears to play role in development of opioid tolerance

New compound appears to play role in development of opioid tolerance

While opioids are a widely used treatment for pain, patients who take them on a regular basis can become tolerant, requiring a higher dose for continued pain relief. In a study published in Anesthesiology, the official medical journal of the American Society of Anesthesiologists, researchers identified a compound that appears to play a role in the development of opioid tolerance. [More]
Increasing opioid doses to manage chronic pain may intensify depression

Increasing opioid doses to manage chronic pain may intensify depression

Patients who increased doses of opioid medicines to manage chronic pain were more likely to experience an increase in depression, according to Saint Louis University findings in Pain. [More]
Experts discuss therapeutic potential of medical cannabis in a symposium organized by MUHC

Experts discuss therapeutic potential of medical cannabis in a symposium organized by MUHC

While debate about recreational marijuana use continues, researchers are investigating the effectiveness of cannabis for treating pain, spasticity, and a host of other medical problems. In a symposium organized by the McGill University Health Centre as part of the 2015 American Association for the Advancement of Science Annual Meeting held this week in San Jose, California, world-renowned experts from North America and the U.K. share their perspectives on the therapeutic potential of medical cannabis and explore the emerging science behind it. [More]
Prevalence of geriatric conditions among older, insured patients with diabetes vary little by ethnicity

Prevalence of geriatric conditions among older, insured patients with diabetes vary little by ethnicity

In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity. [More]
New compound may lead to development of potential therapeutics for neuropathic pain

New compound may lead to development of potential therapeutics for neuropathic pain

A new compound discovered by a team of UC Davis investigators has potent actions against production of a chemical that which is implicated in the development of chronic pain following a peripheral nerve injury in the spinal cord. [More]
Study: Acute psychosocial stress has deleterious effect on the body's ability to modulate pain

Study: Acute psychosocial stress has deleterious effect on the body's ability to modulate pain

Traffic slows to a crawl, then a stop. You are trapped in a bottleneck nightmare, and late for a meeting. The stress takes a toll on you psychologically - but your body is at risk as well, according to a Tel Aviv University researcher. [More]
Policymakers need to look beyond painkiller abuse to reduce opioid overdose deaths, say researchers

Policymakers need to look beyond painkiller abuse to reduce opioid overdose deaths, say researchers

According to researchers at Brandeis University, the University of North Florida and Johns Hopkins University, policymakers must look beyond painkiller abuse, also called non-medical use, in their efforts to reduce opioid overdose deaths. [More]
Northwestern Medicine researchers evaluate unique surgical method to treat chronic amputee pain

Northwestern Medicine researchers evaluate unique surgical method to treat chronic amputee pain

Northwestern Medicine® researchers are leading a new multi-center clinical trial to evaluate a unique surgical method, known as targeted muscle reinnervation (TMR), to treat chronic pain that can result from limb amputation. Around a quarter of all amputees develop chronic pain in the remaining portion of their amputated limb, which can include phantom limb syndrome (pain that is perceived in the portion of the limb that is gone), and prevents many patients from using prostheses. [More]

Nevro obtains new expanded MR-conditional labeling for Senza SCS system

Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received CE Mark for expanded MR-conditional labeling. [More]
Chronic pain common in affective disorders

Chronic pain common in affective disorders

Patients with major depressive disorder or bipolar disorder frequently report chronic pain at multiple sites, research shows. [More]

Nevro gets FDA approval letter for Senza spinal cord stimulation system

Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system. [More]